Find uplifting stories about heroes, innovations, and solutions
5129 results for "triple-negative breast cancer"
Scientists at Oregon Health & Science University created a molecule that shuts down a key enzyme cancer cells need to grow, causing tumors to shrink in mice with triple-negative breast cancer. The breakthrough could lead to new treatments for one of the deadliest forms of breast cancer.
A breast cancer survivor is sharing her healing journey to give others hope. Emily Hester recently appeared on KARK 4 News to talk about her successful treatment for triple-positive breast cancer at CARTI.
Scientists have discovered a molecule that stops triple-negative breast cancer, the most aggressive form that often strikes younger women. The breakthrough treatment shows promise without the toxic side effects that plagued previous cancer therapies.
Scientists have discovered an antibody that successfully halted triple-negative breast cancer in laboratory models, offering hope for one of the most difficult cancers to treat. This breakthrough could lead to better treatment options for thousands of women facing this aggressive disease.
A groundbreaking treatment for triple-negative breast cancer just got FDA approval, giving patients twice as long with controlled disease and six more months of life. Christina, who could barely walk months ago, just walked down the aisle at a wedding thanks to this drug.
A young mother and new nurse given less than 50% odds of surviving triple-negative breast cancer just celebrated 23 years cancer-free. Cheryl Perkins fought through six months of chemotherapy, surgery, and radiation to watch all four daughters grow up.
Two powerful advocates are bringing Triple Negative Breast Cancer survivors together for a vital conversation about the disease that strikes Black women 2.7 times more often than white women. Their event showcases real thrivers beating the odds and shares life-saving information with communities that need it most.
Scientists at the University of Florida have solved a major roadblock in treating one of the most aggressive forms of breast cancer. Their breakthrough delivery system helps powerful anti-tumor drugs reach their targets and survive the journey.
Scientists discovered an existing FDA-approved medication could prevent the deadliest part of breast cancer: when it spreads to other organs. The breakthrough offers new hope for patients with aggressive triple negative breast cancer.
Texas A&M researchers discovered that natural compounds in dark sweet cherries significantly slowed tumor growth and reduced cancer spread in the most aggressive form of breast cancer. The breakthrough offers new hope for treating triple-negative breast cancer, which has limited treatment options.
Scientists created a peptide that acts like a GPS tracker for metastatic breast cancer cells, successfully targeting and destroying them in mice without harming healthy tissue. The discovery could transform treatment for aggressive cancers that have spread beyond their original location.
Scientists discovered how to beat triple-negative breast cancer at its own game by blocking an enzyme that helps tumors survive treatment. The approach not only damages cancer cells directly but also calls in the immune system for backup.
Scientists discovered a powerful natural molecule from a Chinese plant that attacks the most aggressive form of breast cancer in a completely new way. The compound could open doors for patients who have run out of treatment options.
Women with triple-negative breast cancer just gained two powerful new treatment options that work better than standard chemotherapy at keeping the disease under control. The FDA approved Trodelvy alone and combined with immunotherapy as first-line treatments for this aggressive cancer type.
A personalized mRNA vaccine helped 11 women with aggressive breast cancer stay cancer-free for up to six years. The groundbreaking treatment trained their immune systems to recognize and fight cancer cells using their own tumor's genetic code.
Researchers discovered a gene weakness in triple negative breast cancer that could lead to targeted treatments. Early drug tests in mice successfully reduced tumor growth.
A breakthrough treatment is giving hope to women with triple-negative breast cancer, the most aggressive form of the disease. Results show patients lived nearly twice as long compared to standard treatment.
Women with triple-negative breast cancer now have a powerful new first-line treatment option, thanks to research at Emory University. The FDA-approved combination therapy is giving hope to patients who once faced less than a year of survival.
Scientists at Technion-Israel Institute created tiny nanoparticles that stopped deadly triple-negative breast cancer in mice without using any drugs or chemotherapy. The breakthrough treatment works by blocking tumor-feeding cells and letting the body's natural defenses fight back.
Women with triple negative breast cancer now have a powerful new treatment option that nearly doubles the time before their disease progresses. The FDA just approved Datroway, giving hope to patients who previously had limited choices beyond traditional chemotherapy.
Showing 20 of 5129